No Result
View All Result
  • Login
Thursday, August 6, 2026
theadvisertimes.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
theadvisertimes.com
No Result
View All Result
Home Business

Spruce Biosciences (SPRB) Appoints Dale Hooks as CCO and Reports Narrowed $39M 2025 Net Loss

by theadvisertimes.com
5 months ago
in Business
Reading Time: 2 mins read
A A
0
Spruce Biosciences (SPRB) Appoints Dale Hooks as CCO and Reports Narrowed M 2025 Net Loss
Share on FacebookShare on TwitterShare on LInkedIn


Spruce Biosciences Inc. (NASDAQ:SPRB) is one of the best hot stocks to buy according to analysts. On March 9, Spruce Biosciences appointed Dale Hooks as Chief Commercial Officer to lead the company’s transition toward its next phase of growth. Hooks brings nearly 35 years of biopharmaceutical experience to the role, having overseen 21 new product launches throughout his career. His background includes leadership positions at Reata Pharmaceuticals, where he managed one of the most successful rare disease launches in US history, as well as executive roles at Applied Therapeutics, Clovis Oncology, and Genentech.

The appointment comes as Spruce Biosciences Inc. (NASDAQ:SPRB) prepares for the planned BLA submission for tralesinidase alfa/TA-ERT, an enzyme replacement therapy for Sanfilippo Syndrome Type B/MPS IIIB. The CEO emphasized that Hooks’ expertise in building launch-ready infrastructure and commercial strategy will be critical as the company advances what could be the first disease-modifying treatment for this rare neurological disorder.

Spruce Biosciences (SPRB) Appoints Dale Hooks as CCO and Reports Narrowed $39M 2025 Net Loss

In his new role, Hooks will be responsible for shaping the commercial strategy and building high-performing teams to support the potential market entry of TA-ERT. He joins a leadership team currently focused on addressing significant unmet medical needs within the rare disease community.

Spruce Biosciences Inc. (NASDAQ:SPRB) is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

While we acknowledge the potential of SPRB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years

Disclosure: None. Follow Insider Monkey on Google News.



Source link

Tags: 39MappointsBiosciencesCCODaleHooksLossnarrowednetReportsSPRBSpruce
ShareTweetShare
Previous Post

LegalZoom Review 2026: Pros, Cons, Top Alternatives

Next Post

A Quick Fix: Ripple Patches Major Issue That Could Threaten XRP Users On The Ledger

Related Posts

The Key Battles for Senate Control Are Set

The Key Battles for Senate Control Are Set

by theadvisertimes.com
August 6, 2026
0

With yesterday’s victory in Michigan for Abdul El-Sayed, one of the last pieces has fallen into place in key midterm...

Tax Authority warns higher income Israelis are leaving

Tax Authority warns higher income Israelis are leaving

by theadvisertimes.com
August 6, 2026
0

Not only has the number of Israelis emigrating from Israel increased in recent years, but their economic profile has...

GIC subsidiary and promoter Sunu Mathew lead LEAP India’s pre-IPO placement round

GIC subsidiary and promoter Sunu Mathew lead LEAP India’s pre-IPO placement round

by theadvisertimes.com
August 6, 2026
0

KKR-backed supply chain solutions provider LEAP India Ltd. completed its Rs 371.3 crore pre-IPO placement on Thursday. In consultation with...

BBSI narrows 2026 outlook to 3%-4% gross billings growth as it targets 2.7%-2.75% gross margin (NASDAQ:BBSI)

BBSI narrows 2026 outlook to 3%-4% gross billings growth as it targets 2.7%-2.75% gross margin (NASDAQ:BBSI)

by theadvisertimes.com
August 6, 2026
0

Earnings Call Insights: Barrett Business Services, Inc. (BBSI) Q2 2026 Management View "We delivered another quarter of top line growth...

Global Market Today: Asian stocks drop as AI rally pauses, oil dips

Global Market Today: Asian stocks drop as AI rally pauses, oil dips

by theadvisertimes.com
August 5, 2026
0

Asian stocks slipped Thursday after a recent tech-led rally on Wall Street paused. Crude oil edged lower as Iran reached...

SpaceX created a new class of ultrawealthy. Here’s what comes next

SpaceX created a new class of ultrawealthy. Here’s what comes next

by theadvisertimes.com
August 5, 2026
0

At SpaceX’s market debut on June 12, the perfect trade already looked obvious. Shares priced at $135, valuing the company...

Next Post
A Quick Fix: Ripple Patches Major Issue That Could Threaten XRP Users On The Ledger

A Quick Fix: Ripple Patches Major Issue That Could Threaten XRP Users On The Ledger

The Brand–Culture Loop Is Your Startup’s Ultimate Moat

The Brand–Culture Loop Is Your Startup’s Ultimate Moat

  • Trending
  • Comments
  • Latest
SEC pushes private market access, but retail is already in

SEC pushes private market access, but retail is already in

July 16, 2026
How I Maximize My Sapphire Reserve Dining Credit

How I Maximize My Sapphire Reserve Dining Credit

July 10, 2026
The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

June 21, 2026
The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

July 6, 2026
The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

July 20, 2026
The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

May 6, 2026
Iran War: Iran Agreement With Oman Will Not “Open” Strait of Hormuz as Trump Hypes Non-Existent Talks; Ansar Allah Threatens Red Sea Escalation; Trump-Hegseth Row Over Weapons Shortages

Iran War: Iran Agreement With Oman Will Not “Open” Strait of Hormuz as Trump Hypes Non-Existent Talks; Ansar Allah Threatens Red Sea Escalation; Trump-Hegseth Row Over Weapons Shortages

0
This Citi Card’s Dining Perk Scored Me a Hard-to-Get Table

This Citi Card’s Dining Perk Scored Me a Hard-to-Get Table

0
The Key Battles for Senate Control Are Set

The Key Battles for Senate Control Are Set

0
Wall Street’s ‘fear gauge’ is doing something unusual as stocks hit record highs

Wall Street’s ‘fear gauge’ is doing something unusual as stocks hit record highs

0
Tax Authority warns higher income Israelis are leaving

Tax Authority warns higher income Israelis are leaving

0
Lite Strategy Funds .4M Buyback With Litecoin Sales And Covered Calls

Lite Strategy Funds $5.4M Buyback With Litecoin Sales And Covered Calls

0
Iran War: Iran Agreement With Oman Will Not “Open” Strait of Hormuz as Trump Hypes Non-Existent Talks; Ansar Allah Threatens Red Sea Escalation; Trump-Hegseth Row Over Weapons Shortages

Iran War: Iran Agreement With Oman Will Not “Open” Strait of Hormuz as Trump Hypes Non-Existent Talks; Ansar Allah Threatens Red Sea Escalation; Trump-Hegseth Row Over Weapons Shortages

August 6, 2026
The Key Battles for Senate Control Are Set

The Key Battles for Senate Control Are Set

August 6, 2026
Tax Authority warns higher income Israelis are leaving

Tax Authority warns higher income Israelis are leaving

August 6, 2026
Utah Judge Rejects Kalshi’s Federal Shield From Gambling Laws

Utah Judge Rejects Kalshi’s Federal Shield From Gambling Laws

August 6, 2026
GIC subsidiary and promoter Sunu Mathew lead LEAP India’s pre-IPO placement round

GIC subsidiary and promoter Sunu Mathew lead LEAP India’s pre-IPO placement round

August 6, 2026
BBSI narrows 2026 outlook to 3%-4% gross billings growth as it targets 2.7%-2.75% gross margin (NASDAQ:BBSI)

BBSI narrows 2026 outlook to 3%-4% gross billings growth as it targets 2.7%-2.75% gross margin (NASDAQ:BBSI)

August 6, 2026
theadvisertimes.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Iran War: Iran Agreement With Oman Will Not “Open” Strait of Hormuz as Trump Hypes Non-Existent Talks; Ansar Allah Threatens Red Sea Escalation; Trump-Hegseth Row Over Weapons Shortages
  • The Key Battles for Senate Control Are Set
  • Tax Authority warns higher income Israelis are leaving
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • About Us
  • Contact Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.